This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Duolingo (DUOL) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Duolingo (DUOL) is likely to witness a year-over-year increase in revenues for the first quarter of 2024.
Marathon Digital (MARA) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Marathon Digital's (MARA) first-quarter 2024 earnings and revenues are expected to increase year over year.
Will Top-Line Improvement Aid Arm Holdings' (ARM) Q1 Earnings?
by Zacks Equity Research
We expect Arm Holdings (ARM) to witness strong growth across businesses in the fourth quarter of fiscal 2024.
Arq (ARQ) Set to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Arq (ARQ) is expected to record top and bottom-line growth when it reports first-quarter 2024 results.
Jacobs (J) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Digital & technological solutions and growth in infrastructural efforts are likely to have reflected in Jacobs' (J) fiscal second-quarter performance. However, higher expenses might have been a headwind.
New Strong Sell Stocks for April 1st
by Zacks Equity Research
BMRC, CPRI and CMAX have been added to the Zacks Rank #5 (Strong Sell) List on April 1, 2023.
New Strong Sell Stocks for March 28th
by Zacks Equity Research
ASLE, CPRI and CMAX have been added to the Zacks Rank #5 (Strong Sell) List on March 28, 2023.
New Strong Sell Stocks for March 20th
by Zacks Equity Research
CMAX, LNZA and HSON have been added to the Zacks Rank #5 (Strong Sell) List on March 20, 2024.
ZipRecruiter, Inc. (ZIP) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
ZipRecruiter, Inc. (ZIP) delivered earnings and revenue surprises of 130% and 4.47%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
CareMax, Inc. (CMAX) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
CareMax, Inc. (CMAX) delivered earnings and revenue surprises of -150% and 18.83%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Bitfarms Ltd. (BITF) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Bitfarms Ltd. (BITF) delivered earnings and revenue surprises of -40% and 4.20%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
MeridianLink (MLNK) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
MeridianLink (MLNK) delivered earnings and revenue surprises of -50% and 2.38%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
CareMax, Inc. (CMAX) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
CareMax, Inc. (CMAX) delivered earnings and revenue surprises of -20% and 6.74%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Ecovyst (ECVT) Meets Q1 Earnings Estimates
by Zacks Equity Research
Ecovyst (ECVT) delivered earnings and revenue surprises of 0% and 3.45%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
CareMax, Inc. (CMAX) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
CareMax, Inc. (CMAX) delivered earnings and revenue surprises of -433.33% and 7.16%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
CareMax, Inc. (CMAX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
CareMax, Inc. (CMAX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sterling Check Corp. (STER) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Sterling Check Corp. (STER) delivered earnings and revenue surprises of -19.23% and 4.79%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for February 1st
by Zacks Equity Research
BWAY, CMAX and EQBK have been added to the Zacks Rank #5 (Strong Sell) List on February 1, 2023.
New Strong Sell Stocks for January 30th
by Zacks Equity Research
BFC, CMAX and BWAY have been added to the Zacks Rank #5 (Strong Sell) List on January 30, 2023.
CareMax, Inc. (CMAX) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
CareMax, Inc. (CMAX) delivered earnings and revenue surprises of -127.27% and 11.47%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Aptiv PLC (APTV) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Aptiv PLC (APTV) delivered earnings and revenue surprises of 23.08% and 7.71%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for CareMax (CMAX) Stock Options
by Zacks Equity Research
Investors need to pay close attention to CorMedix (CMAX) stock based on the movements in the options market lately.
CareMax (CMAX) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
CareMax (CMAX) has been struggling lately, but the selling pressure may be coming to an end soon.